potent and selective antitumor drug candidate for pancreatic cancer with well-tolerated toxicity
LY255283 is selective
RG14620 also suppresses colony formation(IC50=4 μM) and DNA synthesis (IC50=1
It is highly selective for the H1 receptor and does not cross the blood-brain-barrier
5R)-2-{4-amino-5-iodo-7H-pyrrolo[2
(S, R, S)-AHPC-PEG4-N3 Catalog No.:M13900-2 potent and selective antitumor drug(S,R,S) AHPC PEG4 N3 is a synthesized E3 ligase ligand linker conjugate that incorporates the (S,R,S) AHPC based VHL ligand and 4 unit PEG linker used in PROTAC technology. Product information CAS Number: 1797406 81 5 Molecular Weight: 689. 82 Formula: C32H47N7O8S Chemical Name: (2S,4R) 1 [(2S) 2 (14 azido 3,6,9,12 tetraoxatetradecanamido) 3,3 dimethylbutanoyl] 4 hydroxy N {[4 (4 methyl 1,3 thiazol 5 yl)phenyl]methyl}pyrrolidine 2 carboxamide Smiles: